Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6506
    +0.0006 (+0.10%)
     
  • OIL

    82.89
    +0.08 (+0.10%)
     
  • GOLD

    2,327.10
    -11.30 (-0.48%)
     
  • Bitcoin AUD

    98,772.32
    -4,274.30 (-4.15%)
     
  • CMC Crypto 200

    1,390.02
    -34.08 (-2.39%)
     
  • AUD/EUR

    0.6073
    +0.0003 (+0.05%)
     
  • AUD/NZD

    1.0949
    +0.0007 (+0.06%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,295.93
    +94.66 (+0.55%)
     
  • NIKKEI 225

    37,698.07
    -762.01 (-1.98%)
     

This Valeant Chart Looks Great (Just Don't Try to Measure It)

This Valeant Chart Looks Great (Just Don't Try to Measure It)

Valeant Pharmaceuticals International Inc. told investors Wednesday that new products will be a key part of the drugmaker’s turnaround strategy. Just don’t ask for too many details on the numbers.